DermaSensor’s skin cancer detection device helps clinicians in published study

US-based DermaSensor has announced a newly published study showing that its AI-powered device can improve a primary care physician’s ability to assess moles of concern.

In the prospective study, published in the Journal of the American Board of Family Medicine, three primary care providers used the DermaSensor device to assess 178 skin lesions from 155 patients, comparing its performance to biopsies or a panel of remote dermatologists.